Cargando…
Reduced Activity of Anabolizing Enzymes in 5‐Fluorouracil‐resistant Human Stomach Cancer Cells
The mechanism of resistance to 5‐fluorouracil (5‐FU) was studied with NUGC‐3/5FU/L, a human stomach cancer cell line which had acquired resistance as a consequence of repeated 5‐day exposures to stepwise‐increasing concentrations of 5‐FU in vitro. NUGC‐3/5FU/L was 200‐fold and over 16‐fold resistant...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
1996
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5921054/ https://www.ncbi.nlm.nih.gov/pubmed/8609072 http://dx.doi.org/10.1111/j.1349-7006.1996.tb03161.x |
_version_ | 1783317929598648320 |
---|---|
author | Inaba, Makoto Mitsuhashi, Junko Sawada, Hiroko Miike, Naoko Naoe, Yoshinori Daimon, Aiko Koizumi, Kazuhisa Tsujimoto, Hiroaki Fukushima, Masakazu |
author_facet | Inaba, Makoto Mitsuhashi, Junko Sawada, Hiroko Miike, Naoko Naoe, Yoshinori Daimon, Aiko Koizumi, Kazuhisa Tsujimoto, Hiroaki Fukushima, Masakazu |
author_sort | Inaba, Makoto |
collection | PubMed |
description | The mechanism of resistance to 5‐fluorouracil (5‐FU) was studied with NUGC‐3/5FU/L, a human stomach cancer cell line which had acquired resistance as a consequence of repeated 5‐day exposures to stepwise‐increasing concentrations of 5‐FU in vitro. NUGC‐3/5FU/L was 200‐fold and over 16‐fold resistant to 96‐h and 1‐h exposures to 5‐FU, respectively. NUGC‐3/5FU/L incorporated less 5‐FU into RNA, indicating resistance to the RNA‐directed action of 5‐FU. On the other hand, NUGC‐3/5FU/L also showed resistance to in situ thymidylate synthase (TS) inhibition by 5‐FU. Polymerase chain reaction‐single‐strand conformation polymorphism analysis of TS cDNA and a FdUMP ligand binding assay showed that quantitative and qualitative alterations of TS are not responsible for this resistance. In contrast, the ability to metabolize 5‐FU to its active metabolites, FUTP and FdUMP, was reduced in NUGC‐3/5FU/L. We found that not only the activities of uridine phosphorylase/kinase and orotate phosphoribosyl‐transferase (OPRT), but also the level of phosphoribosyl pyrophosphate, a cosubstrate for OPRT, were significantly lower in NUGC‐3/5FU/L than in the parent NUGC‐3. These results indicated that resistance to 5‐FU in NUGC‐3/5FU/L is due to reduced activities of 5‐FU‐anabolizing enzymes, but not to an alteration of TS. 2′‐Deoxyinosine effectively enhanced TS inhibition by 5‐FU in the resistant cells, thus markedly sensitizing them to 5‐FU. |
format | Online Article Text |
id | pubmed-5921054 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1996 |
publisher | Blackwell Publishing Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-59210542018-05-11 Reduced Activity of Anabolizing Enzymes in 5‐Fluorouracil‐resistant Human Stomach Cancer Cells Inaba, Makoto Mitsuhashi, Junko Sawada, Hiroko Miike, Naoko Naoe, Yoshinori Daimon, Aiko Koizumi, Kazuhisa Tsujimoto, Hiroaki Fukushima, Masakazu Jpn J Cancer Res Article The mechanism of resistance to 5‐fluorouracil (5‐FU) was studied with NUGC‐3/5FU/L, a human stomach cancer cell line which had acquired resistance as a consequence of repeated 5‐day exposures to stepwise‐increasing concentrations of 5‐FU in vitro. NUGC‐3/5FU/L was 200‐fold and over 16‐fold resistant to 96‐h and 1‐h exposures to 5‐FU, respectively. NUGC‐3/5FU/L incorporated less 5‐FU into RNA, indicating resistance to the RNA‐directed action of 5‐FU. On the other hand, NUGC‐3/5FU/L also showed resistance to in situ thymidylate synthase (TS) inhibition by 5‐FU. Polymerase chain reaction‐single‐strand conformation polymorphism analysis of TS cDNA and a FdUMP ligand binding assay showed that quantitative and qualitative alterations of TS are not responsible for this resistance. In contrast, the ability to metabolize 5‐FU to its active metabolites, FUTP and FdUMP, was reduced in NUGC‐3/5FU/L. We found that not only the activities of uridine phosphorylase/kinase and orotate phosphoribosyl‐transferase (OPRT), but also the level of phosphoribosyl pyrophosphate, a cosubstrate for OPRT, were significantly lower in NUGC‐3/5FU/L than in the parent NUGC‐3. These results indicated that resistance to 5‐FU in NUGC‐3/5FU/L is due to reduced activities of 5‐FU‐anabolizing enzymes, but not to an alteration of TS. 2′‐Deoxyinosine effectively enhanced TS inhibition by 5‐FU in the resistant cells, thus markedly sensitizing them to 5‐FU. Blackwell Publishing Ltd 1996-02 /pmc/articles/PMC5921054/ /pubmed/8609072 http://dx.doi.org/10.1111/j.1349-7006.1996.tb03161.x Text en |
spellingShingle | Article Inaba, Makoto Mitsuhashi, Junko Sawada, Hiroko Miike, Naoko Naoe, Yoshinori Daimon, Aiko Koizumi, Kazuhisa Tsujimoto, Hiroaki Fukushima, Masakazu Reduced Activity of Anabolizing Enzymes in 5‐Fluorouracil‐resistant Human Stomach Cancer Cells |
title | Reduced Activity of Anabolizing Enzymes in 5‐Fluorouracil‐resistant Human Stomach Cancer Cells |
title_full | Reduced Activity of Anabolizing Enzymes in 5‐Fluorouracil‐resistant Human Stomach Cancer Cells |
title_fullStr | Reduced Activity of Anabolizing Enzymes in 5‐Fluorouracil‐resistant Human Stomach Cancer Cells |
title_full_unstemmed | Reduced Activity of Anabolizing Enzymes in 5‐Fluorouracil‐resistant Human Stomach Cancer Cells |
title_short | Reduced Activity of Anabolizing Enzymes in 5‐Fluorouracil‐resistant Human Stomach Cancer Cells |
title_sort | reduced activity of anabolizing enzymes in 5‐fluorouracil‐resistant human stomach cancer cells |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5921054/ https://www.ncbi.nlm.nih.gov/pubmed/8609072 http://dx.doi.org/10.1111/j.1349-7006.1996.tb03161.x |
work_keys_str_mv | AT inabamakoto reducedactivityofanabolizingenzymesin5fluorouracilresistanthumanstomachcancercells AT mitsuhashijunko reducedactivityofanabolizingenzymesin5fluorouracilresistanthumanstomachcancercells AT sawadahiroko reducedactivityofanabolizingenzymesin5fluorouracilresistanthumanstomachcancercells AT miikenaoko reducedactivityofanabolizingenzymesin5fluorouracilresistanthumanstomachcancercells AT naoeyoshinori reducedactivityofanabolizingenzymesin5fluorouracilresistanthumanstomachcancercells AT daimonaiko reducedactivityofanabolizingenzymesin5fluorouracilresistanthumanstomachcancercells AT koizumikazuhisa reducedactivityofanabolizingenzymesin5fluorouracilresistanthumanstomachcancercells AT tsujimotohiroaki reducedactivityofanabolizingenzymesin5fluorouracilresistanthumanstomachcancercells AT fukushimamasakazu reducedactivityofanabolizingenzymesin5fluorouracilresistanthumanstomachcancercells |